Skip to content
value.today

Rodin Therapeutics, Inc.

Total raised
$11 M
1 round on record
Latest round
$11 M
Aug 2017
First round on record
Aug 2017
Today
Acquired
Acquired by Alkermes plc.

Acquired

Matched to this startup by its exact name; the buyer's report is the source.

Acquisition of Rodin Therapeutics, Inc.
AcquiredBuyerAcquisition dateCompletionPriceStakeSource
Rodin Therapeutics, IncAlkermes plc.Nov 2019———Annual report

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Rodin Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2017$11 MNo. 1$10 to $50 million

Rodin Therapeutics, Inc.: Raise no. 1, Aug 2017

Investors in this round

6 investors had bought by the notice of Sep 14, 2017: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $27 M offered; $16 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Rosenberg · Executive Officer, Director
  • Bruce Booth · Director
  • Kees Been · Director
  • Samantha Singer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam Rosenberg, President & Chief Executive Officer. Newest notice filed Sep 14, 2017. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Rodin Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2017).

    SEC Form D · Sep 2017

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Sep 2017

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Rodin Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Rodin Therapeutics, Inc.
NameRoleNamed in
Adam RosenbergExecutive officerSep 2017
Adam RosenbergDirectorSep 2017
Bruce BoothDirectorSep 2017
Kees BeenDirectorSep 2017
Samantha SingerDirectorSep 2017

Acquired (Jan 1, 2019). Acquired by Alkermes plc..